Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Drug therapy for epilepsy

B R Parks¹, V G Dostrow, S L Noble

¹University of Mississippi, University.

American Family Physician

|September 1, 1994

Summary

This summary is machine-generated.

Epilepsy affects 1-3% of the U.S. population. New epilepsy drugs and individualized treatment aim to improve seizure control for more patients beyond the current 70%.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients.

Journal of child neurology·2001

Same author

Anticonvulsant blood levels: historical review with a pediatric focus.

Journal of child neurology·2000

Same author

Onychomycosis: improved cure rates with itraconazole and terbinafine.

The Journal of the American Board of Family Practice·2000

Same author

Cyclooxygenase-2 enzyme inhibitors: place in therapy.

American family physician·2000

Same author

Recognition and treatment of autism: the role of the family physician.

Journal of the Mississippi State Medical Association·1999

Same author

Movers and shakers: a clinician's guide to laxatives.

Pediatric annals·1999

Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026

Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026

Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026

Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026

Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026

Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

See all related articles

Area of Science:

Neurology
Pharmacology
Clinical Medicine

Background:

Epilepsy is a chronic neurological disorder affecting 1-3% of the U.S. population, characterized by recurrent seizures.
Current epilepsy management relies on six established drugs, used alone or in combination.
Recent advancements have introduced three new therapeutic agents for epilepsy treatment.

Purpose of the Study:

To review current and emerging therapeutic options for epilepsy management.
To emphasize the importance of individualized treatment strategies for epilepsy patients.
To explore the potential of new agents and improved management to enhance seizure control rates.

Main Methods:

Review of existing literature on epilepsy pharmacotherapy.
Analysis of pharmacokinetic and side-effect profiles of established and new antiepileptic drugs.

Related Experiment Videos

Consideration of patient-specific factors including epilepsy type, drug interactions, and compliance.

Main Results:

Approximately 70% of patients currently achieve good seizure control with existing therapies.
Three new antiepileptic agents have recently become available, expanding treatment options.
Individualized therapy selection is crucial for optimizing patient outcomes.

Conclusions:

Optimizing epilepsy treatment requires a personalized approach, considering drug properties and patient factors.
The introduction of new antiepileptic drugs offers potential for improved seizure control.
Further improvements in therapeutic management are expected to increase the percentage of patients achieving good epilepsy control.